UNIGE document Scientific Article
previous document  unige:84447  next document
add to browser collection
Title

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options

Authors
Disanto, Giulio
Benkert, Pascal
Lorscheider, Johannes
Mueller, Stefanie
Vehoff, Jochen
Zecca, Chiara
Ramseier, Simon
Achtnichts, Lutz
show hidden authors show all authors [1 - 26]
Published in PLOS ONE. 2016, vol. 11, no. 3, p. e0152347
Abstract The mechanisms leading to disability and the long-term efficacy and safety of disease modifying drugs (DMDs) in multiple sclerosis (MS) are unclear. We aimed at building a prospective cohort of MS patients with standardized collection of demographic, clinical, MRI data and body fluids that can be used to develop prognostic indicators and biomarkers of disease evolution and therapeutic response. The Swiss MS Cohort (SMSC) is a prospective observational study performed across seven Swiss MS centers including patients with MS, clinically isolated syndrome (CIS), radiologically isolated syndrome or neuromyelitis optica. Neurological and radiological assessments and biological samples are collected every 6-12 months. We recruited 872 patients (clinically isolated syndrome [CIS] 5.5%, relapsing-remitting MS [RRMS] 85.8%, primary progressive MS [PPMS] 3.5%, secondary progressive MS [SPMS] 5.2%) between June 2012 and July 2015. We performed 2,286 visits (median follow-up 398 days) and collected 2,274 serum, plasma and blood samples, 152 cerebrospinal fluid samples and 1,276 brain MRI scans. 158 relapses occurred and expanded disability status scale (EDSS) scores increased in PPMS, SPMS and RRMS patients experiencing relapses. Most RRMS patients were treated with fingolimod (33.4%), natalizumab (24.5%) or injectable DMDs (13.6%). The SMSC will provide relevant information regarding DMDs efficacy and safety and will serve as a comprehensive infrastructure available for nested research projects.
Identifiers
PMID: 27032105
Full text
Article (Author postprint) (1.2 MB) - public document Free access
Structures
Research group Caroline Pot
Citation
(ISO format)
DISANTO, Giulio et al. The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. In: PLOS ONE, 2016, vol. 11, n° 3, p. e0152347. https://archive-ouverte.unige.ch/unige:84447

82 hits

84 downloads

Update

Deposited on : 2016-06-13

Export document
Format :
Citation style :